Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: Oxaliplatin versus mitomycin C

Annals of Surgical Oncology

Volumn 18, Issue 1, 2011, Pages 174-180

  Rueth, Natasha M ^a   Murray, Sara E ^a   Huddleston, Stephen J ^a   Abbott, Andrea M ^a   Greeno, Edward W ^a   Kirstein, Mark N ^b   Tuttle, Todd M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; OXALIPLATIN; RINGER LACTATE SOLUTION; SODIUM;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; DEMOGRAPHY; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; MALE; MESOTHELIOMA; MIDDLE AGED; MITOMYCIN; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; WATER-ELECTROLYTE IMBALANCE;

EID: 78651364947     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1210-1     Document Type: Article

References (26)

1. B Sadeghi C Arvieux O Glehen AC Beaujard M Rivoire J Baulieux, et al. 2000 Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358 363 1:STN:280: DC%2BD3c7gvVOntg%3D%3D 10.1002/(SICI)1097-0142(20000115)88:2<358::AID- CNCR16>3.0.CO;2-O 10640968
2. BW Loggie RA Fleming RP McQuellon GB Russell KR Geisinger 2000 Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin Am Surg 66 561 568 1:STN:280:DC%2BD3M%2Fhs1ahsg%3D%3D 10888132
3. PH Sugarbaker D Chang 1999 Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 727 731 1:STN:280:DC%2BD3c%2Fos1aisw%3D%3D 10.1007/s10434-999-0727-7 10622499
4. T Andre C Boni L Mounedji-Boudiaf M Navarro J Tabernero T Hickish, et al. 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343 2351 1:CAS:528:DC%2BD2cXks1Gjt78%3D 10.1056/NEJMoa032709 15175436
5. RM Goldberg S Gill 2004 Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer Cancer Chemother Pharmacol 54 Suppl 1 S57 S64 1:CAS:528:DC%2BD2cXhtFagtrrN 15309516
6. RM Goldberg DJ Sargent RF Morton CS Fuchs RK Ramanathan SK Williamson, et al. 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23 30 1:CAS:528: DC%2BD2cXpsVKitbY%3D 10.1200/JCO.2004.09.046 14665611
7. A Grothey RM Goldberg 2004 A review of oxaliplatin and its clinical use in colorectal cancer Expert Opin Pharmacother 5 2159 2170 1:CAS:528: DC%2BD2cXotVOntbY%3D 10.1517/14656566.5.10.2159 15461551
8. A Grothey D Sargent RM Goldberg HJ Schmoll 2004 Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment J Clin Oncol 22 1209 1214 1:CAS:528:DC%2BD2cXpsVGktLo%3D 10.1200/JCO.2004.11.037 15051767
9. A de Gramont A Figer M Seymour M Homerin A Hmissi J Cassidy, et al. 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947 10944126
10. S Giacchetti B Perpoint R Zidani N Le Bail R Faggiuolo C Focan, et al. 2000 Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 18 136 147 1:CAS:528:DC%2BD3cXmtFSqsw%3D%3D 10623704
11. WP Ceelen M Peeters P Houtmeyers C Breusegem F De Somer P Pattyn 2008 Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis Ann Surg Oncol 15 535 541 10.1245/s10434-007-9648-5 17960463
12. JH Stewart IV P Shen G Russell J Fenstermaker L McWilliams FM Coldrun, et al. 2008 A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers Ann Surg Oncol 15 2137 2145 10.1245/s10434-008-9967-1 18493824
13. TD Yan D Black PH Sugarbaker J Zhu Y Yonemura G Petrou, et al. 2007 A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer Ann Surg Oncol 14 2702 2713 10.1245/s10434-007-9487-4 17653801
14. TD Yan M Deraco D Baratti S Kusamura D Elias O Glehen, et al. 2009 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 6237 6242 10.1200/JCO.2009.23.9640 19917862
15. TD Yan D Black R Savady PH Sugarbaker 2006 Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol 24 4011 4019 10.1200/JCO.2006.07.1142 16921055
16. VJ Verwaal S van Ruth E de Bree GW van Sloothen H van Tinteren H Boot, et al. 2003 Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737 3743 10.1200/JCO.2003.04.187 14551293
17. JJ Hall BW Loggie P Shen S Beamer L Douglas Case R McQuellon, et al. 2004 Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer J Gastrointest Surg 8 454 463 10.1016/j.gassur.2003.12. 014 15120371
18. J Esquivel R Sticca P Sugarbaker E Levine TD Yan R Alexander, et al. 2007 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology Ann Surg Oncol 14 128 133 1:STN:280:DC%2BD28jjtVyjsA%3D%3D 17072675
19. VJ Verwaal H van Tinteren SV Ruth FA Zoetmulder 2004 Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol 85 61 67 10.1002/jso.20013 14755505
20. MN Kirstein SA Root MM Moore KM Wieman BW Williams PA Jacobson, et al. 2008 Exposure-response relationships for oxaliplatin-treated colon cancer cells Anticancer Drugs 19 37 44 1:CAS:528:DC%2BD2sXhtlCrurzL 10.1097/CAD. 0b013e3282f07791 18043128
21. D Elias JH Lefevre J Chevalier A Brouquet F Marchal JM Classe, et al. 2009 Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 681 685 10.1200/JCO.2008.19.7160 19103728
22. D Elias D Goere F Blot V Billard M Pocard N Kohneh-Shahri, et al. 2007 Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients Ann Surg Oncol 14 1818 1824 10.1245/s10434-007-9348-1 17356950
23. E Curis K Provost D Bouvet I Nicolis S Crauste-Manciet D Brossard, et al. 2001 Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS J Synchrotron Radiat 8 716 718 1:CAS:528:DC%2BD3MXhs1akt70%3D 10.1107/S0909049500017775 11512906
24. E Jerremalm M Hedeland I Wallin U Bondesson H Ehrsson 2004 Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex Pharm Res 21 891 894 1:CAS:528: DC%2BD2cXjs1Kjuro%3D 10.1023/B:PHAM.0000026444.67883.83 15180350
25. F De Somer W Ceelen J Delanghe D De Smet M Vanackere P Pattyn, et al. 2008 Severe hyponatremia, hyperglycemia, and hyperlactatemia are associated with intraoperative hyperthermic intraperitoneal chemoperfusion with oxaliplatin Perit Dial Int 28 61 66 18178949
26. TM Tuttle Y Zhang E Greeno A Knutsen 2006 Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 13 1627 1632 10.1245/s10434-006-9186-6 17013686